PB
The startup operates a proprietary precision medicine platform that integrates digital pathology, AI, ultra-rapid molecular diagnostics, and liquid biopsy to enhance cancer treatment accessibility at community cancer centers. This system addresses the need for advanced tissue and blood diagnostics, enabling timely access to personalized therapies for patients.
Updated 3 months ago
Funding
$9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a proprietary precision medicine platform that integrates digital pathology, AI, ultra-rapid molecular diagnostics, and liquid biopsy to enhance cancer treatment accessibility at community cancer centers. This system addresses the need for advanced tissue and blood diagnostics, enabling timely access to personalized therapies for patients.